Akèy › Melanom › Arizona › Scottsdale
Etid klinik pou Melanom nan Scottsdale, AZ
10 etid pou Melanom ap chèche patisipan nan sit nan ak bò kote Scottsdale (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Ap rekriteFaz 1/2
- HonorHealth Research Institute, Scottsdale
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Ap rekriteFaz 1/2
- Arizona State University-Honor Health Research Institute, Scottsdale
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Ap rekriteFaz 1/2
- HonorHealth Research Institute, Scottsdale
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Ap rekriteFaz 3
- Mayo Clinic Scottsdale - PPDS, Scottsdale
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Ap rekriteFaz 2/3
- HonorHealth Research Insisute, Scottsdale
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Ap rekriteFaz 1/2
- HonorHealth Research and Innovation Institute, Scottsdale
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Scottsdale
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Ap rekriteFaz 1/2
- Mayo Clinic in Arizona, Scottsdale
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Ap rekriteFaz 1/2
- HonorHealth Research Institute, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1
- HonorHealth Research Institute, Scottsdale
Etid Melanom nan lòt vil
- Houston, TX59 etid
- New York City, NY38 etid
- Los Angeles, CA34 etid
- Nashville, TN33 etid
- Pittsburgh, PA31 etid
- Boston, MA26 etid
- Philadelphia, PA23 etid
- San Francisco, CA22 etid
- Columbus, OH21 etid
- Durham, NC21 etid
- Atlanta, GA21 etid
- Salt Lake City, UT21 etid
Lòt etid nan Scottsdale
- Kansè nan tete18 etid
- Kansè (tout kalite)18 etid
- Kansè Metastatik17 etid
- Kansè pwostat17 etid
- Kansè kolorektal16 etid
- Kansè Poumon ki pa ti selil15 etid
- Kansè pankreyas13 etid
- Kolit Ulseratif8 etid
- Kansè poumon8 etid
- Kansè fwa (Kasinòm epatoselilè)7 etid
- Maladi Alzheimer7 etid
- Kansè tete negatif triple7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.